San Ysidro School District, CA GO Debt Rating Raised To 'A+' After Budget Cuts Jun 11

  • ID: 1815529
  • June 2011
  • Standard & Poors
1 of 3

CHARLOTTESVILLE (Standard & Poor's) June 7, 2011--Standard & Poor's Ratings Services said it raised the rating on San Ysidro School District, Calif.'s general obligation (GO) debt to 'A+' from 'A' and the rating on the certificates of participation to 'A' from 'A-'. At the same time, we assigned an 'A+' rating to the district's latest GO bonds. The outlook on the ratings is stable. "The upgrade is based on the district's recent budget cuts which will help maintain its strong reserve position," said Standard & Poor's credit analyst Lisa Schroeer. The 'A+' rating reflects our view of the district's: Strong economy with access to diverse employment opportunities throughout the San Diego area, and Strong available reserves when taking into account...

Companies mentioned in this report are: San Ysidro Sch Dist
Action: New Rating
Action: Outlook: Stable
Action: Upgraded

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Research type: News
This product is a is a brief one-page announcement of no more than 500 words with a quote from the analyst. It is media and investor focused with no accompanying commentary article.

Note: Product cover images may vary from those shown
2 of 3

San Ysidro Sch Dist

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown




Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer Inc.